Preventing excessive bleeding in patients with von Willebrand disease.
Gill
Joan Cox
JC
D005169:Factor VIII / Q000627:therapeutic use; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D011292:Premedication; D014842:von Willebrand Diseases / Q000145:classification / Q000150:complications*; D014841:von Willebrand Factor / Q000627:therapeutic use
D014841:von Willebrand Factor; D005169:Factor VIII